Cencora, a global healthcare company, has expanded its Sure Supply Program to include 200 critical medications, including several oncology treatments, in response to ongoing drug shortages. This marks a 350% increase since the initiative first launched in 2021.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
